Arthritis study: Tesla BioHealing
Official title Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
ClinicalTrials.gov ID: NCT06915012
What this study is testing
- What it's testing
- The study aims to find out whether biophoton therapy can reduce chronic severe pain in people with arthritis.
- Who it's for
- Adults who have chronic severe arthritis pain.
- What's involved
- Participants will place a small device near their body while sleeping for at least 8 hours each night for 12 weeks and will fill out pain and quality‑of‑life questionnaires every two weeks.
- Time commitment
- The trial lasts about 12 weeks, with regular questionnaire visits (about every two weeks) and nightly use of the device.
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Willing and able to give informed consent for participation in the trial.
- Is able and willing to comply with all trial requirements.
- Male or female aged 18-80 years old with chronic severe arthritis pain.
- ≥3 months duration of chronic severe arthritis pain.
- a current VAS pain rating ≥5/10.
You likely can't join if
- Untreated psychiatric disturbances that would affect trial participation as judged by the Caregiver or by the clinical study medical professional
- Who relies on ventilators
- Who had deep brain stimulators, or pacemakers, or implantable electronic devices
- Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history...
- Is participating in another investigational drug or device trial
- Has an active infectious disease, such as COVID-19
See the full eligibility criteria
- Willing and able to give informed consent for participation in the trial.
- Is able and willing to comply with all trial requirements.
- Male or female aged 18-80 years old with chronic severe arthritis pain.
- ≥3 months duration of chronic severe arthritis pain.
- a current VAS pain rating ≥5/10.
- Able to complete the treatment for the study period.
- Must be fluent in English.
- Untreated psychiatric disturbances that would affect trial participation as judged by the Caregiver or by the clinical study medical professional
- Who relies on ventilators
- Who had deep brain stimulators, or pacemakers, or implantable electronic devices
- Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe...
- Is participating in another investigational drug or device trial
- Has an active infectious disease, such as COVID-19
- Pregnant women.
The study team makes the final eligibility decision.
Where it is enrolling
- Butler, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Butler, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.